Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Counterfeit Drugs, Food Safety Are Expected Focus Of New FDA Bill In House

Executive Summary

Tightened security for counterfeit drugs and food imports are slated to be addressed in another bill aimed at boosting FDA's oversight powers, Energy and Commerce Committee Chairman John Dingell, D-Mich., said during markup of drug safety legislation

You may also be interested in...



Counterfeiters Increasingly Target Chronic Illness - Reps. Buyer, Matheson

Drugs to treat chronic conditions are increasingly being counterfeited, a problem that helps underscore the need for electronic pedigree legislation, Rep. Steve Buyer, R-Ind., said at an April 22 press conference to promote the "Safeguarding America's Pharmaceuticals Act.

Counterfeiters Increasingly Target Chronic Illness - Reps. Buyer, Matheson

Drugs to treat chronic conditions are increasingly being counterfeited, a problem that helps underscore the need for electronic pedigree legislation, Rep. Steve Buyer, R-Ind., said at an April 22 press conference to promote the "Safeguarding America's Pharmaceuticals Act.

House Bill Requires Standard Numerical Identifiers For Drug Tracking By 2010

Legislation setting specific deadlines to implement drug tracking requirements was introduced April 17 by Reps. Steve Buyer, R-Ind., and Jim Matheson, D-Utah

Related Content

UsernamePublicRestriction

Register

PS048515

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel